Abstract
We evaluated the use of the T2Bacteria panel for diagnosis of bloodstream infection in pediatric HCT/CT patients. Overall, the panel expedited recognition of bloodstream infections, providing results sooner than Gram stain and final blood culture identification. The T2Bacteria panel contributed to a change to appropriate therapy in 23% of patients with concordant positive results.